Updated 20:04 GMT, 28 Oct 2026 SPX 7,744.01 +0.28% NDX 29,813.16 +0.55% VIX 16.87 -3.71% GOLD 4,077.30 +0.07% CL 102.52 +2.62% BTC 81,597.92 +0.98%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,077 +0.07% BTC $81,598 +0.98% VIX 16.87 −3.71% latest tape · as of 20:04 UTC
The Screen · ETF

Vanguard FTSE Developed Markets ETF

VEA · NYSE ARCA · USD

The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex U.S.

Not yet scored
69.05 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago

Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price69.05 USD at the 23 Oct 2026 close
  • Our ratingAvoid, current read markdown
  • Ethical screenNot yet scored
  • OptionsOpen interest leans heavily to calls (put/call 0.06)
  • Last reviewed23 Oct 2026 (5 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 69.05 against the desk's fair-value range, over the last year.

Current read
Markdown ?
AVOID · screened 2026-10-23
  • Trend Markdown
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.06, read 2026-10-27
  • Ethical screen not yet scored
Price69.05 USD
Ethical score30.0/100
RatingAVOID
Our investment reviews on this name
2026-10-25Read Markdown69.30-0.4% to today ✓Distribution gives way to Markdown first Markdown read since September
2026-10-02Read Distribution71.38-3.3% to today ✓Markdown gives way to Distribution with volume flow in agreement
2026-09-16Read Markdown71.31-3.2% to today ✓Markup gives way to Markdown with volume flow in agreement
2026-07-02Read Markup71.31-3.2% to today First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markdown label.

Vanguard FTSE Developed Markets ETF holds its Markdown at $69.05. The statistical read favours the sellers, held for 22 days.

As held on the ledger · 2026-10-23
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 22 days
Price at the screen$69.05
Valuation19.08 trailing · N/A forward price to earnings
Values screenNot scored · score 30.0
The Workings

Five Screens, Shown in Full

This security has not been fully scored against the values screen yet.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

The Read, in Plain English

Vanguard FTSE Developed Markets ETF clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads AVOID

Price History & Projections
$73.1$56.3$39.5TODAY5y agoPROJECTION

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Trailing P/E19.1xreasonably valued
Dividend yield261.00%
52-week range54.63 - 72.32

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

VEA trades on NYSE ARCA. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-25 Markdown · changed $69.30 +0.0% Entry 9

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-10-18 Distribution $69.30 -2.9% Entry 8

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-10-11 Distribution $71.38 +0.0% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-10-02 Distribution · changed $71.38 +0.1% Entry 6

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-09-16 Markdown · changed $71.31 +0.0% Entry 5

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-08-16 Markup $71.31 +0.0% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-07-18 Markup $71.31 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 11%.

2026-07-03 Markup $71.31 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markup $71.31 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Political Ledger · Congressional Disclosures
Disclosures naming VEA
DatePoliticianPartyTypeAmount
2026-05-27 John Boozman Republican sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $70.82 -2.8% · $972 -2.8%
2 months $67.74 +1.6% · $1,016 +1.6%
3 months $64.46 +6.8% $0.11 $1,069 +6.9%
6 months $61.65 +11.6% $1.15 $1,135 +13.5%
1 year $54.70 +25.8% $1.88 $1,292 +29.2%
2 years $47.54 +44.7% $3.44 $1,520 +52.0%
3 years $41.83 +64.5% $5.08 $1,766 +76.6%
5 years $45.43 +51.5% $7.84 $1,687 +68.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever VEA does next, these words stay.

Vanguard FTSE Developed Markets ETF · VEA · Markdown · $69.05
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.